Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elio Mazzone

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
European Urology Oncology|June 16, 2019
Re: Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, et al. Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer. Eur Urol Oncol 2019;2:320-328Elio Mazzone, Pierre I Karakiewicz
Current Opinion in Urology|November 15, 2019
Training in robot-assisted surgeryStefano Puliatti, Elio Mazzone, Paolo Dell'Oglio
Turkish Journal of Urology|December 18, 2019
Outcomes report of the first ERUS robotic urology curriculum-trained surgeon in Turkey: the importance of structured and validated training programs for global outcomes improvementElio Mazzone, Paolo Dell'Oglio, Alexandre Mottrie
Current Opinion in Urology|November 13, 2019
Robot-assisted radical prostatectomy vs. open radical prostatectomy: latest evidences on perioperative, functional and oncological outcomesPaolo Dell'Oglio, Alexandre Mottrie, Elio Mazzone
Translational Andrology and Urology|July 18, 2020
Highlighting the road towards new disease-specific comorbidity indicesPaolo Dell'Oglio, Elio Mazzone, Zhe Tian, et al.
BMC Urology|April 29, 2021
Surgical benchmarks, mid-term oncological outcomes, and impact of surgical team composition on simultaneous enbloc robot-assisted radical cystectomy and nephroureterectomyStephan Buse, Assen Alexandrov, Elio Mazzone, et al.
European Urology|June 6, 2022
Re: Deepika Reddy, Max Peters, Taimur T. Shah, et al. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol 2022;81:407-13Francesco Montorsi, Armando Stabile, Elio Mazzone, et al.
Annals of Translational Medicine|February 12, 2019
Benefit of nephron sparing surgery translates into lower cancer specific mortality in patients with localized renal cell carcinomaFrancesco A Mistretta, Elio Mazzone, Sophie Knipper, et al.
Current Opinion in Urology|December 4, 2024
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospectsChris Ho-Ming Wong, Rossella Nicoletti, Elio Mazzone, et al.
Archivos Espanoles De Urologia|October 4, 2019
Usefulness of the Indocyanine Green (ICG) Immunofluorescence in laparoscopic and robotic partial nephrectomyAbhishek Pandey, Paolo Dell'Oglio, Elio Mazzone, et al.
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
European Urology Oncology|June 16, 2019
Re: Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, et al. Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer. Eur Urol Oncol 2019;2:320-328Elio Mazzone, Pierre I Karakiewicz
Current Opinion in Urology|November 15, 2019
Training in robot-assisted surgeryStefano Puliatti, Elio Mazzone, Paolo Dell'Oglio
Turkish Journal of Urology|December 18, 2019
Outcomes report of the first ERUS robotic urology curriculum-trained surgeon in Turkey: the importance of structured and validated training programs for global outcomes improvementElio Mazzone, Paolo Dell'Oglio, Alexandre Mottrie
Current Opinion in Urology|November 13, 2019
Robot-assisted radical prostatectomy vs. open radical prostatectomy: latest evidences on perioperative, functional and oncological outcomesPaolo Dell'Oglio, Alexandre Mottrie, Elio Mazzone
Translational Andrology and Urology|July 18, 2020
Highlighting the road towards new disease-specific comorbidity indicesPaolo Dell'Oglio, Elio Mazzone, Zhe Tian, et al.
BMC Urology|April 29, 2021
Surgical benchmarks, mid-term oncological outcomes, and impact of surgical team composition on simultaneous enbloc robot-assisted radical cystectomy and nephroureterectomyStephan Buse, Assen Alexandrov, Elio Mazzone, et al.
European Urology|June 6, 2022
Re: Deepika Reddy, Max Peters, Taimur T. Shah, et al. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol 2022;81:407-13Francesco Montorsi, Armando Stabile, Elio Mazzone, et al.
Annals of Translational Medicine|February 12, 2019
Benefit of nephron sparing surgery translates into lower cancer specific mortality in patients with localized renal cell carcinomaFrancesco A Mistretta, Elio Mazzone, Sophie Knipper, et al.
Current Opinion in Urology|December 4, 2024
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospectsChris Ho-Ming Wong, Rossella Nicoletti, Elio Mazzone, et al.
Archivos Espanoles De Urologia|October 4, 2019
Usefulness of the Indocyanine Green (ICG) Immunofluorescence in laparoscopic and robotic partial nephrectomyAbhishek Pandey, Paolo Dell'Oglio, Elio Mazzone, et al.
Pageof 19